This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3l9n
From Proteopedia
(Difference between revisions)
| (3 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| + | |||
==crystal structure of PKAB3 (pka triple mutant V123A, L173M, Q181K) with compound 27== | ==crystal structure of PKAB3 (pka triple mutant V123A, L173M, Q181K) with compound 27== | ||
| - | <StructureSection load='3l9n' size='340' side='right' caption='[[3l9n]], [[Resolution|resolution]] 2.00Å' scene=''> | + | <StructureSection load='3l9n' size='340' side='right'caption='[[3l9n]], [[Resolution|resolution]] 2.00Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[3l9n]] is a 2 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[3l9n]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3L9N OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3L9N FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=L9N:(2S)-N~1~-[5-(1H-INDAZOL-5-YL)-1,3,4-THIADIAZOL-2-YL]-3-(4-METHYLPHENYL)PROPANE-1,2-DIAMINE'>L9N</scene> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=L9N:(2S)-N~1~-[5-(1H-INDAZOL-5-YL)-1,3,4-THIADIAZOL-2-YL]-3-(4-METHYLPHENYL)PROPANE-1,2-DIAMINE'>L9N</scene>, <scene name='pdbligand=SEP:PHOSPHOSERINE'>SEP</scene>, <scene name='pdbligand=TPO:PHOSPHOTHREONINE'>TPO</scene></td></tr> | |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3l9n FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3l9n OCA], [https://pdbe.org/3l9n PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3l9n RCSB], [https://www.ebi.ac.uk/pdbsum/3l9n PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3l9n ProSAT]</span></td></tr> | |
| - | + | ||
| - | + | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/IPKA_HUMAN IPKA_HUMAN] Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulatory chains. | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 18: | Line 18: | ||
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
| + | <div class="pdbe-citations 3l9n" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[CAMP-dependent protein kinase 3D structures|CAMP-dependent protein kinase 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
| Line 23: | Line 27: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: Huang | + | [[Category: Huang X]] |
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
crystal structure of PKAB3 (pka triple mutant V123A, L173M, Q181K) with compound 27
| |||||||||||
